Antitumor activity of a folate-cleaving enzyme, carboxypeptidase G 1 .
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology; D002268:Carboxypeptidases / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D002279:Carcinoma 256, Walker / Q000188:drug therapy; D002455:Cell Division / Q000187:drug effects; D002460:Cell Line; D002478:Cells, Cultured; D002999:Clone Cells; D004273:DNA, Neoplasm / Q000096:biosynthesis; D003857:Deoxyuridine / Q000378:metabolism; D003864:Depression, Chemical; D005260:Female; D005492:Folic Acid / Q000097:blood / Q000378:metabolism; D005494:Folic Acid Deficiency / Q000139:chemically induced; D006801:Humans; D007274:Injections, Intraperitoneal; D007939:Leukemia L1210 / Q000188:drug therapy; D008099:Liver / Q000378:metabolism; D008223:Lymphoma / Q000188:drug therapy; D008297:Male; D051379:Mice; D008806:Mice, Inbred AKR; D008811:Mice, Inbred DBA; D008815:Mice, Inbred Strains; D009374:Neoplasms, Experimental / Q000188:drug therapy / Q000378:metabolism; D051381:Rats; D012510:Sarcoma 180 / Q000188:drug therapy; D013936:Thymidine / Q000378:metabolism; D013997:Time Factors; D014316:Tritium
D000970:Antineoplastic Agents; D004273:DNA, Neoplasm; D014316:Tritium; D005492:Folic Acid; D002268:Carboxypeptidases; D013936:Thymidine; D003857:Deoxyuridine